SiteBridge Research

SiteBridge Research

SiteBridge Research was founded to bridge the gap between community physicians and clinical trial sponsors. Its model converts independent practices into regulated research sites by providing staff, training, and technology, enabling patients to access novel therapies without leaving their local provider. The firm's footprint spans at least seven US markets, including Louisville, Chicago, San Diego, and San Francisco. SiteBridge functions as a turn-key infrastructure provider for decentralized trials. Rather than funding therapeutics, it deploys capital into site activation, regulatory readiness, and patient recruitment logistics. The firm's network aggregates 271 practice locations and a reach of 464,000 patients, positioning it as a scaled entry point for sponsors seeking diverse participant pools. Its primary counterparties are pharmaceutical companies and contract research organizations rather than direct portfolio companies. The organization lists offices across major US biotech hubs — San Diego, San Francisco, and Chapel Hill — alongside operations in Portsmouth and Chicago. Its stated client base includes clinical practices seeking ancillary revenue and sponsors requiring compliant, on-budget trial execution. SiteBridge's structure as an Integrated Research Organization differentiates it from both pure site management organizations and traditional contract research organizations. It takes on the regulatory and operational liabilities of trial conduct at the physician level, creating a hybrid entity that sits between the sponsor and the patient in the clinical development value chain.